FP7 logo euThe ESNATS project has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n° HEALTH-F5-2008-201619

Embryonic Stem cell-based Novel Alternative Testing Strategies

What is new about the ESNATS approach?

ESNATS uses human ES cells to develop in vitro test systems for developmental and acute toxicity. As ES cells can develop into virtually any cell type of the body, they are an ideal source of human cells, thus avoiding problems of interspecies differences. Furthermore, human ES cells offer a unique tissue culture model for developmental processes and can be used for studying developmental toxicity as well.

Top ^